| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/22/2003 | EP1276903A2 Method for determination of gene function |
| 01/22/2003 | EP1276902A2 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 01/22/2003 | EP1276901A2 A universal nucleic acid amplification system for nucleic acids in a sample |
| 01/22/2003 | EP1276900A2 Integrated systems and methods for diversity generation and screening |
| 01/22/2003 | EP1276899A2 Ibd-related polymorphisms |
| 01/22/2003 | EP1276898A1 Flavivirus detection and quantification assay |
| 01/22/2003 | EP1276897A2 Live cell procedures to identify compounds modulating intracellular distribution of phosphodiesterase (pde) enzymes |
| 01/22/2003 | EP1276896A2 Method of identifying and producing antigen peptides and use thereof as vaccines |
| 01/22/2003 | EP1276895A2 Method for the identification of active site protease inactivators |
| 01/22/2003 | EP1276894A2 Method for screening of microorganisms under nutrient limited conditions |
| 01/22/2003 | EP1276893A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 01/22/2003 | EP1276892A2 A bacterial two-hybrid system for protein interaction screening |
| 01/22/2003 | EP1276887A2 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 01/22/2003 | EP1276885A2 Trophic conversion of obligate phototrophic algae through metabolic engineering |
| 01/22/2003 | EP1276882A2 Method for genetically modifying a plant |
| 01/22/2003 | EP1276880A2 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 01/22/2003 | EP1276879A1 MUIR-TORRE-LIKE SYNDROME IN Fhit DEFICIENT MICE |
| 01/22/2003 | EP1276876A2 Expression-regulating sequences and expression products in the field of filamentous fungi: chrysosporium |
| 01/22/2003 | EP1276873A2 Human kinase proteins and polynucleotides encoding the same |
| 01/22/2003 | EP1276872A2 A thymus expressed human cytochrome p450 (p450tec) |
| 01/22/2003 | EP1276868A2 Identification of human gaba transporter |
| 01/22/2003 | EP1276865A2 Methods for binding an exogenous molecule to cellular chromatin |
| 01/22/2003 | EP1276864A1 Primer for diagnosis of one or more kinds of cancer |
| 01/22/2003 | EP1276863A1 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 01/22/2003 | EP1276860A2 Databases of regulatory sequences; methods of making and using same |
| 01/22/2003 | EP1276859A2 Targeted modification of chromatin structure |
| 01/22/2003 | EP1276857A1 Signal sequence trapping |
| 01/22/2003 | EP1276855A2 Methods of constructing display libraries of genetic packages for members of a diverse family of peptides |
| 01/22/2003 | EP1276848A2 Apparatus and methods for testing effects of materials and surface coatings on the formation of biofilms |
| 01/22/2003 | EP1276764A1 Human polynucleotides, polypeptides, and antibodies |
| 01/22/2003 | EP1276760A2 Polyamide nucleic acid derivatives, agents and methods for producing them |
| 01/22/2003 | EP1276753A2 Method of determining a risk of hyperglycemic patients of developing a cardiovascular disease |
| 01/22/2003 | EP1276752A2 Method of evaluating a risk of a subject of developing vascular complications |
| 01/22/2003 | EP1276751A2 Novel nucleic acids and polypeptides |
| 01/22/2003 | EP1276702A2 Compositions and methods for detecting and quantifying gene expression |
| 01/22/2003 | EP1276503A2 Compositions comprising an inhibitor of an acrab-like efflux pump for reducing microbial resistance to drugs |
| 01/22/2003 | EP1276379A1 In situ growth, freezing and testing of cultured cells |
| 01/22/2003 | EP1179183A4 A method for identifying pre-neoplastic and/or neoplastic states in mammals |
| 01/22/2003 | EP1173771A4 Procoagulant assay |
| 01/22/2003 | EP1151138A4 Use of fluorescent molecular beacons in the detection of methylated nucleic acids |
| 01/22/2003 | EP1099271B1 Electrochemical methods for generation of a biological proton motive force and pyridine nucleotide cofactor regeneration |
| 01/22/2003 | EP1095277B1 A system for cell-based screening |
| 01/22/2003 | EP1051510A4 A rapid method for the assessment of the inhibition and kill of anaerobic bacteria by toxic compounds |
| 01/22/2003 | EP1021724B1 Assays and probes with enzyme labels |
| 01/22/2003 | EP1009855A4 Method for separating cells |
| 01/22/2003 | EP0954607A4 Genetic alterations associated with prostate cancer |
| 01/22/2003 | EP0873423A4 Methods for detecting mutations associated with hypertrophic cardiomyopathy |
| 01/22/2003 | EP0853679B1 Expression monitoring by hybridization to high density oligonucleotide arrays |
| 01/22/2003 | EP0765399B1 Detecting bacteria |
| 01/22/2003 | EP0610436B1 Hepatitis-c virus testing |
| 01/22/2003 | CN1393020A Electromagnetic device and high-voltage geratating device and method of producing electromagnetic device |
| 01/22/2003 | CN1392901A Fast quantitatively measuring oxided and reduced glutahione by enzyme method |
| 01/22/2003 | CN1392270A Detection method and device for point mutation gene |
| 01/22/2003 | CN1392269A Nano gold mark silver dyeing detection method of gene chip |
| 01/22/2003 | CN1392268A Detection type gene chip for detecting various peptitis |
| 01/22/2003 | CN1392267A cDNA reducing hybrid difference display method on cDMA library base |
| 01/22/2003 | CN1392266A Quick gram staining liquid and method |
| 01/22/2003 | CN1392259A CR1 gene ralative to cell reconstitution, conduction and death |
| 01/22/2003 | CN1099596C Method for detecting exogenous origin gene integrator animal embryon |
| 01/22/2003 | CN1099465C Ovulation-testing reagent kit for natural contraception and its making method |
| 01/22/2003 | CN1099464C Activity test method of telomerase |
| 01/21/2003 | WO2004009834A2 Novel nucleic acids and secreted polypeptides |
| 01/21/2003 | US6509450 Immunoassay for quantification of C-terminal telopeptides of type I collagen in human serum |
| 01/21/2003 | US6509448 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/21/2003 | US6509447 G protein chimeras and methods of screening compounds |
| 01/21/2003 | US6509446 Recombinant genetic information (DNA or RNA), consisting a Chicken Anemia Virus (CAV)-specific nucleotide sequence, useful for diagonestics, vaccination or protein production |
| 01/21/2003 | US6509442 Novel mutations which are associated with aberrant iron metabolism, absorption, or storage, or in advanced cases, clinical hemochromatosis |
| 01/21/2003 | US6509316 Administering therapeutically effective amount of inhibitor of phospholipase A2 to animal |
| 01/21/2003 | US6509187 Method and device for collection and preparation of tissue samples for molecular genetic diagnostics |
| 01/21/2003 | US6509172 Isolated, truncated nucleic acid which are members of the gage, and uses thereof |
| 01/21/2003 | US6509167 High throughput sarcomeric assay |
| 01/21/2003 | US6509162 Methods for selectively modulating survivin apoptosis pathways |
| 01/21/2003 | US6509160 Cleaving polynucleotide sequence, first ligating an adapter with a recognition site, second cleaving the polynucleotide sequence resulting from first ligation, second ligating and determining the sequence between the first and second adapter |
| 01/21/2003 | US6509158 Nucleic acid molecule is elongated and fixed along its length onto a solid planar surface so that said nucleic acid molecule is individually analyzable and accessible for enzymatic reactions |
| 01/21/2003 | US6509157 Kit for nucleic acid amplification comprising a pair of primers, wherein at least one primer of said pair is reversibly blocked by the covalent attachment of a triarylmethyl group to 3' terminal hydroxy group |
| 01/21/2003 | US6509155 Characterization, diagnosis, prevention, and treatment of cell signaling, immune, and cell proliferative disorders, particularly colon cancer |
| 01/21/2003 | US6509153 Genetic markers of toxicity preparation and uses |
| 01/21/2003 | US6509152 Immunosuppressant target proteins |
| 01/21/2003 | US6509151 DNA molecule encoding a Mycobacterium protein and conferring on Mycobacterium tuberculosis an ability to enter mammalian cells and to survive within macrophages |
| 01/21/2003 | US6509148 Method for fabricating biosensors using hydrophilic polyurethane |
| 01/21/2003 | US6509018 Expressed peptides, in particular a strain designated YBF30; including V3 loop region and corresponding nucleotide sequences |
| 01/21/2003 | US6509016 Delaying recurrence of ganglioside 2 associated tumors; antibody comprising the light and heavy chain variable region sequences contained in seq id no: 2 and 4 |
| 01/21/2003 | CA2453344A1 Novel nucleic acids and secreted polypeptides |
| 01/21/2003 | CA2328194C A system for cell-based screening |
| 01/21/2003 | CA2256686C Multicomponent analysis method including the determination of a statistical confidence interval |
| 01/21/2003 | CA2187624C Method of eliminating genetic routes for bacteriophage evolution and products produced thereby |
| 01/21/2003 | CA2100159C Rapid assays for amplification products |
| 01/21/2003 | CA1341417C Hirudine-expressing vectors, altered cells, and a process for hirudine preparation |
| 01/19/2003 | CA2390971A1 Identification of compounds for inhibiting mta/adohcy nucleosidases |
| 01/18/2003 | CA2352702A1 Novel human proton gated ion channel |
| 01/17/2003 | CA2407295A1 Transgenic non-human mammal |
| 01/17/2003 | CA2393895A1 Serological test for isav in fish |
| 01/16/2003 | WO2003005038A1 Identification of modulators of neurotransmitter activity of xanthurenic acid |
| 01/16/2003 | WO2003005036A2 Epf receptor assays, compounds and therapeutic compositions |
| 01/16/2003 | WO2003005035A1 Chp for use as marker for sepsis-type inflammatory diseases |
| 01/16/2003 | WO2003005022A1 A method for solid state genome analysis |
| 01/16/2003 | WO2003004995A2 High-throughput stem cell assay of hematopoietic stem and progenitor cell proliferation |
| 01/16/2003 | WO2003004992A2 Mammalian sweet and amino acid heterodimeric taste receptors |
| 01/16/2003 | WO2003004991A2 Method for detection, quantitation and breakpoint cluster region determination of fusion transcripts |
| 01/16/2003 | WO2003004989A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer |